It's been a while since the pharmaceutical industry last saw a year like 2023, when the U.S. Food and Drug Administration (FDA) approved a slew of groundbreaking and life-changing medications that represent a surge in innovation-and a potential boon to the drugmakers' bottom lines.
Eisai and Biogen kicked off the year with the approval of lecanemab (Leqembi) for Alzheimer's disease, which is the second medication designed to treat the root causes of the memory-robbing condition, but appears to be the most effective. GSK and Pfizer dropped the first-ever vaccines for RSV in adults, giving older and pregnant people a way to protect themselves and, in the case of expectant mothers, their newborns as well-from a potentially deadly respiratory disease. Biogen and Sage Therapeutics received approval for a first-ever oral treatment for postpartum depression, zuranolone (Zurzuvae), and the FDA also allowed biotech companies Intellia Therapeutics and Regeneron Pharmaceuticals to start late-stage testing of the first gene-editing treatment, using CRISPR technology, inside patients.
This story is from the December 25, 2023 edition of Time.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 25, 2023 edition of Time.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Paris Mayor Anne Hidalgo is reimagining the Olympics
When Paris kicks off the Olympic Games on July 26, it will be with athletes floating on an armada of boats down the Seine River, rather than marching in a stadium as it has always been.
TIME 100 HEALTH-TITANS
Last May, U.S. Surgeon General Vivek Murthy issued an advisory about the profound consequences of loneliness and isolation-a departure from the type of standard medical conditions his predecessors prioritized.
TIME 100 HEALTH-CATALYSTS
It's been a long time since there was good news about Parkinson's disease, a neurodegenerative condition that affects more than 8 million people worldwide.
TIME 100 HEALTH-LEADERS
'Catastrophic.' -BASHAR MURAD ON THE HEALTH SITUATION IN GAZA
TIME 100 HEALTH-PIONEERS
In the wake of the pandemic, a new era emerges-marked by fresh discoveries, novel treatments, and global victories over disease. These are the most influential people in health in 2024
A Man in Full, adapted and redacted
TOM WOLFE'S A MAN IN FULL IS A MASSIVE BOOK, IN MORE ways than one. The 742-page social novel about a swaggering Atlanta real estate mogul, which took Wolfe over a decade to write, sold a jaw-dropping 1.4 million hardcover copies after its publication in 1998. The book's themes-money, power, race, masculinity--are just as grand.
The golden age of Ryan Gosling is upon us
IN DEREK CIANFRANCE'S 2010 LOVE-ON-THErocks heartbreaker Blue Valentine, Ryan Gosling plays a husband and father, Dean, who appears to be nothing but an annoyance to his wife, Michelle Williams' Cindy, a harried nurse.
A MARRIAGE OF FOOD AND FICTION
In the kitchen with Rachel Khong, author of Real Americans
Greek Revival
PRIME MINISTER KYRIAKOS MITSOTAKIS IS DETERMINED TO MAKE GREECE THE COMEBACK STORY OF THE DECADE
HOLDING COURT
AT 20, DEFENDING U.S. OPEN CHAMPION COCO GAUFF IS MOVING INTO A NEW PHASE OF HER CAREER